Activity modification during the healing phase allows tissue repair without constant re-injury
Once in the bloodstream, cibinetide binds this receptor on immune cells (especially myeloid cells like macrophages and microglia), endothelial cells, and other stressed tissues, triggering intracellular signaling (e.g., JAK/STAT, PI3K/Akt, and inhibition of NF-B p65) that dampens innate immune overactivation, suppresses production and systemic release of pro-inflammatory cytokines (TNF-, IL-1, IL-6, IL-12/IL-23), reduces chemokine-driven cell infiltration, lowers oxidative stress and nitric oxide overproduction, and promotes anti-inflammatory shifts and cell survival
This innovative peptide works by disrupting the interaction between FOXO4 and p53 proteins within senescent cells
Chronic conditions involving ongoing tissue damage, such as tendinopathy, may also respond to the peptide enhanced repair signaling
Q19: Which form is better for anti-aging: liposomal glutathione or L-glutathione
